Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
Posted 03 February 2013 - 11:55 PM
In this observational study, tocilizumab and abatacept appeared to be safe and effective on joints, in patients with refractory systemic sclerosis. PubMed. Ann rheumatologist Dis. 2012 Dec 19. (Also see: Skeletal Involvement: Myositis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)